Skip to main content
. 2023 Sep 1;55(9):2039–2050. doi: 10.1038/s12276-023-01082-1

Fig. 3. Drug profile of BMK-C203 and BMK-C205.

Fig. 3

a Structure-guided BMK-I-152 analog synthesis that replaced the exocyclic alkylamino group of BMK-I-152. b The IC50 values of BMK-C203 and BMK-C205 (n = 3). c Liver microsomal stabilities (percentage remaining after 30 min) (n = 3). *Verapamil: reference chemical for liver microsomal stability (1 μM). d CYP450 inhibition assay (percentage of control activity at 10 μM). *Ketoconazole: CYP3A4 inhibitor (0.1 μM), reference chemical for the CYP450 inhibition assay (n = 3). e PK profiles of antalarmin, BMK-I-152, BMK-C203, and BMK-C205 in SD rats (n = 3).